April 2026 Update: Adderall and Generic Amphetamine Mixed Salts Shortage
By Benjamin Zohar, NCACIP Medically reviewed by Brandon McNally, RN
Where Things Stand as of April 30, 2026
The shortage of amphetamine mixed salts immediate-release tablets continues to affect multiple manufacturers, strengths, and NDCs. This includes several generic versions of [Adderall](/addiction/adderall-addiction) immediate-release tablets. Some products are listed as available, some are in limited supply, and others remain on back order.
The shortage is not limited to one manufacturer. Reported causes include active pharmaceutical ingredient delays, increased demand, shipping delays, discontinued products, and manufacturer-specific supply interruptions. Several companies have limited supply available, while others have back orders without a clear release date.
For background on how this shortage developed, see our earlier guide: ADHD Medication Shortage 2026: What Long Island Families Should Know.
Which Adderall Products Are Affected?
The current shortage mainly involves amphetamine mixed salts immediate-release (IR) tablets, the generic form commonly substituted for Adderall IR. Affected strengths include:
- 5 mg
- 7.5 mg
- 10 mg
- 12.5 mg
- 15 mg
- 20 mg
- 30 mg
Manufacturers with products listed in shortage or limited supply include Alvogen, Elite Laboratories, Epic Pharma, Lannett, Oryza Pharmaceuticals, Rhodes, Sandoz, and Teva generics. Some manufacturers have available products in certain strengths, while other strengths from the same company remain limited or unavailable.
Why the Shortage Is Still Happening
The shortage remains complex because different manufacturers report different causes. Some report shortages of active pharmaceutical ingredients. Others cite increased demand, shipping delays, or limited manufacturing capacity. A few companies have discontinued certain amphetamine mixed salts products altogether.
This means patients may find one strength or manufacturer unavailable while another strength, brand, or generic manufacturer is still obtainable. Availability can also vary by pharmacy, distributor, region, and insurance formulary.
Current Availability Notes
- Teva brand-name Adderall immediate-release tablets are listed as available in multiple strengths.
- Several generic amphetamine mixed salts products remain in limited supply or on back order.
- Oryza Pharmaceuticals estimates some back-ordered products may be released in June 2026.
- Rhodes has multiple strengths on back order and cannot estimate a release date.
- Solco, Mylan, and Zydus have discontinued certain amphetamine mixed salts immediate-release products.
Availability can change week to week. Pharmacies on Long Island, including in Nassau and Suffolk counties, may have different stock than national reports suggest. Learn more about Nassau County treatment resources.
What Patients Should Do During the Shortage
Patients should not change their dose, split medication differently, stop medication abruptly, or switch products without speaking with their prescriber.
If a pharmacy cannot fill a prescription, patients can ask their prescriber or pharmacist about appropriate alternatives, including:
- A different strength of the same medication
- A different generic manufacturer
- An extended-release formulation
- A non-stimulant or alternative ADHD medication, when clinically appropriate
Because stimulant medications are controlled substances, transferring prescriptions or changing products can require additional communication between the prescriber, pharmacy, and insurer. Patients may need to call pharmacies ahead of time, confirm availability, and ask their prescriber whether a revised prescription is needed.
Safety Concerns During Stimulant Shortages
The CDC has warned that disrupted access to prescription stimulants may increase several risks, including:
- Untreated ADHD symptoms
- Unsafe medication sharing
- Use of counterfeit pills
- Use of illicit stimulants
Patients should avoid buying pills from non-pharmacy sources, even if the pills appear to be Adderall or another prescription stimulant. Counterfeit pills may contain methamphetamine, fentanyl, or other dangerous substances.
Anyone who experiences chest pain, severe anxiety, confusion, suicidal thoughts, psychosis, overdose symptoms, or severe withdrawal-related distress should seek urgent medical help.
Bottom Line
The Adderall shortage remains active in 2026, especially for generic amphetamine mixed salts immediate-release tablets. Some products are available, but supply is inconsistent. Patients should work directly with their prescriber and pharmacist to identify safe, legal, and clinically appropriate options.
If concerns about stimulant use, counterfeit pills, or stimulant misuse arise during the shortage, a recovery advocate on Long Island can help connect you with appropriate, confidential support.
Source note: This update is based on the April 30, 2026 shortage information for amphetamine mixed salts immediate-release tablets, including manufacturer availability, shortage reasons, resupply notes, and CDC safety guidance. This article is for educational purposes only and is not medical advice. Always speak with your prescriber or pharmacist about medication decisions.